Developer docs
API playgroundTry for free, no card

Search company profiles

King Faisal Specialist Hospital and Research

Full company profile

uuid0004gvj

Namestring
King Faisal Specialist Hospital and Research
Legal namestring
King Faisal Specialist Hospital and Research Center
Websiteurl
kfshrc.edu.sa
Company typeenum
Private
Founded yearint
1975
Descriptiontext

King Faisal Specialist Hospital and Research Centre (KFSH&RC) is a state-linked, non-traded healthcare and research institution founded in 1975 and headquartered in Riyadh, Kingdom of Saudi Arabia. It operates hospital campuses in Riyadh (over 1,500 inpatient beds, the flagship and main research center), Jeddah (approximately 470 beds, with a telemedicine network linked to Riyadh) and Madinah (a 300-bed smart hospital), and added Almather Hospital as a fourth site in August 2026. Care delivery is organized into named Centres of Excellence (Cancer, Organ Transplant, Heart, Genomics Medicine, Medical, Neuroscience, Surgical, Pediatrics & Women's, Clinical Services, Perioperative & Intensive Care) covering more than 65 specialties, with 1,092 organ transplants performed in a single year and 4M+ patients treated annually across 107+ nationalities by over 13,500 professionals drawn from more than 67 nationalities, including 1,750 doctors. Governance sits with a 13-member Board chaired by Mr. Mazin Alromaih (since 2023), whose membership includes the Ministry of Health, Ministry of Finance, Public Investment Fund, Center for National Health Insurance and the Council of Economic and Development Affairs; the entity has no disclosed parent, holding company or equity investors and trades as a non-listed institutional provider rather than a for-profit corporate.

The underlying technical base combines clinical, manufacturing and research assets. Surgical capability includes fully robotic and single-port robotic platforms that produced the world's first fully robotic heart transplant, the world's first fully robotic liver transplant and a world-first single-port robotic living donor liver resection, plus integrated robotic deep brain stimulation. In-house additive manufacturing (fused deposition modeling, stereolithography, digital light processing and multi-jetting) produces surgical planning models, biocompatible cutting guides, orthotics and prosthetics. Radiopharmaceuticals are manufactured on three on-site cyclotrons, supplying more than 30 PET and SPECT agents to around 50 hospitals in Saudi Arabia under international GMP and SFDA standards, and the Secondary Standards Dosimetry Laboratory operates as an IAEA-recognized Collaborating Centre and national/regional dosimetry reference. The research arm under Chief Research and Innovation Officer Prof. Jackie Y. Ying integrates biomarker discovery, multi-omics, bioinformatics and AI, with over 200 primary patents granted or pending (42 licensed to multinational and start-up companies) and an integrated genomic medicine model highlighted by Nature Genetics. Digital access runs through the Altakhassusi patient portal/app, e-Services, referral entry, the 199019 helpline, iLearn, Motamarat and the iSupplier portal; no public or partner-facing developer API is exposed.

Economically the institution runs a transaction-based clinical model: revenue comes from tertiary and quaternary patient care (beds, intensive care, surgery, transplantation, oncology, specialist consultations) collected through patient billing and third-party health insurance reimbursement, with billing and insurance data shared with insurers for payment and coverage, and a separate patient-accounts function operated through the Admission Office. Non-clinical lines are smaller but meaningful: radiopharmaceutical product supply to external hospitals (usage-based), clinical trial management and investigational therapeutics including sponsor-funded therapies (four high-impact partnership agreements plus roughly one new agreement annually, alongside CRO and contract research services), 3D printing services, comparative medicine contract research under AAALAC accreditation, and education and training programs spanning 66 residency and 27 fellowship tracks. Patient charges, insurance tariffs and research-service fees are not publicly disclosed, so pricing mechanics and payer mix are not observable from the source data.

Short descriptiontext

State-linked Saudi hospital and research institution operating campuses in Riyadh, Jeddah, Madinah and Almather, delivering tertiary and quaternary transplant, oncology, cardiac and genomic medicine to 4M+ patients a year, funded by patient billing and health insurance reimbursement.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersRiyadh, Saudi Arabia
HQ citystring
Riyadh
HQ countrystring
Saudi Arabia
HQ regionstring
Middle East
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tertiary and quaternary healthcare, specialist hospital services, organ transplantation programs, oncology treatment services, clinical research services
Industry4 codes
PRIMARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAHAA
Cardiac & Cardiothoracic Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAAAM
Hospital-Integrated Cancer Centers (Acute Oncology Programs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
SECONDARYHLAFAKAB
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
NAICS code3 codes
  • Hospitals622
  • General Medical and Surgical Hospitals6221
  • Specialty (except Psychiatric and Substance Abuse) Hospitals62231
SIC code3 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Medical Laboratories8071
Product category
Tertiary Care Hospital Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model6 records
1Clinical services (patient care and treatment)
TypeTransaction Fee
Description

Revenue is generated from the delivery of tertiary and quaternary clinical care across three hospital campuses (Riyadh, Jeddah, Madinah), including inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations. Billing data (health data used for billing purposes) and insurance data (bank account details, health insurance details, credit/debit cards) are collected and shared with insurers for payment and coverage, indicating third-party payer reimbursement as a core collection mechanism.

kfshrc.edu.sa
2Radiopharmaceutical manufacturing (supply to hospitals)
TypeUsage Based
Description

The Cyclotron and Radiopharmaceuticals unit produces on-demand ready-to-use doses of more than 30 radiopharmaceuticals supplied to around 50 hospitals throughout Saudi Arabia, under international GMP and SFDA standards — a product supply revenue line to external institutional customers.

kfshrc.edu.sa
3Clinical trials and investigational therapeutics
TypeProfessional Services
Description

Clinical trial management services, including sponsor-funded investigational therapies and cost avoidance where trial participants receive industry-sponsored therapies that the institution would otherwise fund; includes four high-impact partnership agreements with one new agreement annually, plus CRO/contract research services.

kfshrc.edu.sa
43D printing and custom medical device services
TypeProfessional Services
Description

Award-winning in-house 3D printing service offered to clinical and research departments and external organisations, covering surgical planning models, biocompatible cutting guides, orthotics and prosthetics, and research prototypes.

kfshrc.edu.sa
5Comparative medicine contract research organization services
TypeProfessional Services
Description

Animal models, veterinary care and operating rooms made available to external organisations under contract and collaboration, including medical device testing, immune therapies and surgical innovation studies for local and international universities and hospitals.

6Education, training and professional development programs
TypeProfessional Services
Description

Academic & Training Affairs runs undergraduate, postgraduate (66 residency and 27 fellowship programs), non-medical training, simulation centre and continuing medical education programs, plus scholarships, some with international accreditation, open to employees, interns/students and external organisations.

kfshrc.edu.sa
Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Altakhassusi (KFSH App)
Description

Patient mobile application and personal health records portal used to manage appointments, access medical records, view test results and find doctors; also published as the Altakhassusi medical record service.

kfshrc.edu.sa
+3 more records
Core offering1 text field

King Faisal Specialist Hospital & Research Centre provides tertiary and quaternary hospital care through three campuses in Riyadh, Jeddah and Madinah, covering inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations across more than 65 specialties. Its care is organised into named Centres of Excellence (including Cancer, Organ Transplant, Heart, Genomics Medicine, Neurosciences, Surgical and Perioperative & Intensive Care) and is extended by an in-house Research Centre that sells contract research services such as clinical trials management, 3D printing, radiopharmaceutical manufacturing and dosimetry calibration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • Reduced cost of CAR-T therapy by 80 percent
+9 more records
Product overview1 text field

KFSH&RC operates not a single software product but a multi-campus healthcare and research platform: three hospital campuses (Riyadh, Jeddah, Madinah) plus the new Almather Hospital, organized into named Centres of Excellence (Cancer, Organ Transplant, Heart, Genomics Medicine, Medical, Neuroscience, Surgical, Pediatrics & Women's, Clinical Services and Perioperative & Intensive Care), supported by a set of standalone Research Services (Biomedical Physics, Clinical Trials, Comparative Medicine, Cyclotron and Radiopharmaceuticals, Investigational Therapeutics, Research Regulation and Compliance and 3D Printing) and a digital layer of patient-facing and staff-facing platforms (the Altakhassusi/KFSH App patient portal, e-Services, iLearn learning platform, Motamarat CME app, Health Sciences Digital Library and the iSupplier portal). On top of these foundations KFSH&RC layers a growing applied-AI product set (AI-powered ECG analysis, a CAR T-cell eligibility and risk assessment platform, and an applied AI ecosystem for radiology), alongside an in-house 3D printing service for precision surgery and robotic surgery platforms used in transplant and neurosurgical programs.

Product and service27 records
1KFSH&RC Riyadh Hospital
CategoryHospital campus
Description

Flagship 1,500-bed hospital and main research centre of KFSH&RC, delivering advanced medical and surgical care for patients across Saudi Arabia and internationally, leading organ transplantation, cancer treatment and genomic medicine programmes; JCI-accredited and home of the world's first fully robotic heart transplant.

2KFSH&RC Jeddah Hospital
CategoryHospital campus
Description

Approximately 470-bed specialist care, training and research campus on the Red Sea coast with general and specialised wards, advanced cardiac care, paediatric surgery and oncology units, and a telemedicine network linked to Riyadh for complex consultations.

3KFSH&RC Madinah Hospital
CategoryHospital campus
Description

Newest 300-bed hospital in the network in the Holy City, featuring smart hospital systems, smart rooms, an infusion centre and operating theatres, with a focus on cancer, ophthalmology, critical care and women's health.

4Organ Transplant Centre of Excellence
CategoryCentre of excellence
Description

Twelve-specialty centre leading the Middle East in organ transplantation, performing 1,092 organ transplants in a single year, including the world's first fully robotic liver transplant, and the world's first single-port robotic living donor liver resection.

5Heart Centre of Excellence
CategoryCentre of excellence
Description

Five-specialty centre operating the only active heart transplant programme in the Kingdom of Saudi Arabia and the Gulf region and the largest in Asia Pacific, ranking among the top 10% of transplant centres worldwide; home of the world's first fully robotic heart transplant.

6Cancer Centre of Excellence
CategoryCentre of excellence
Description

Described as the Gulf's largest premier cancer facility with seven specialties, treating nearly a quarter of all cancer cases in Saudi Arabia annually, backed by the King Abdullah Center for Oncology and Liver Diseases (KACOLD) with 300 smart-room beds, 96 infusion centre beds and 8 operating theatres.

7Genomics Medicine Centre of Excellence
CategoryCentre of excellence
Description

Four-specialty centre applying genomic testing to tailor treatments to individual genetic profiles, linked to KFSHRC's integrated genomic medicine model that was highlighted by Nature Genetics as it scaled genomic medicine from research into clinical decision-making.

8Medical Centre of Excellence
CategoryCentre of excellence
Description

Eight expert teams under one roof spanning immunology, endocrinology, gastroenterology, infectious diseases, internal medicine, nephrology, pulmonary medicine and rheumatology.

9Neuroscience Centre of Excellence
CategoryCentre of excellence
Description

Eight-specialty multidisciplinary centre delivering treatments for brain tumours, stroke, epilepsy and movement disorders, including robotic deep brain stimulation and stereoelectroencephalography procedures.

10Surgical Centre of Excellence
CategoryCentre of excellence
Description

Six-specialty surgical centre covering minimally invasive and complex operations, supported by the hospital's integrated robotic surgery platform and by in-house 3D printing for surgical planning models and biocompatible cutting guides.

11Pediatrics & Women's Centre of Excellence
CategoryCentre of excellence
Description

Three-specialty centre offering specialised paediatric treatments, including the King Fahad National Centre for Children's Cancer and the largest regional paediatric stem cell transplant programme, and comprehensive women's health services for families.

12Clinical Services Centre of Excellence
CategoryCentre of excellence
Description

Clinical services hub within KFSH&RC's Centres of Excellence, grouping specialised clinical service lines delivered across the network's hospital campuses.

13Perioperative & Intensive Care Centre of Excellence
CategoryCentre of excellence
Description

Perioperative services and intensive care unit capability supporting complex surgery, including the Riyadh campus's advanced intensive care units.

143D Printing Service
CategoryResearch service / additive manufacturing
Description

On-site additive manufacturing service using fused deposition modeling, stereolithography, digital light processing and multi-jetting, offered to clinical and research departments and external organisations for surgical planning models, biocompatible cutting guides, custom orthotics and prosthetics, and research prototypes and bioprinting.

15Clinical Trials Unit
CategoryResearch service
Description

Central hub coordinating end-to-end clinical trial management from activation to completion for sponsors, CROs and investigators, advising on feasibility and trial operations; almost half of all active clinical trials in Saudi Arabia are conducted at KFSHRC.

16Cyclotron and Radiopharmaceuticals
CategoryResearch service / manufacturing
Description

On-demand production of more than 30 different PET and SPECT radiopharmaceuticals using three on-site cyclotrons under international GMP and SFDA standards, supplying ready-to-use patient doses to around 50 hospitals throughout Saudi Arabia, with quality control covering radionuclide identification, radiochemical purity, pH, sterility and residual solvents.

17Biomedical Physics Department (incl. Secondary Standards Dosimetry Laboratory)
CategoryResearch service
Description

Medical physics, radiation protection, quality assurance, calibration and dosimetry services; its Secondary Standards Dosimetry Laboratory is an IAEA-recognised Collaborating Centre and a national and regional reference centre for radiation dosimetry providing traceable calibration to international primary standards.

18Comparative Medicine
CategoryResearch service
Description

AAALAC-accredited animal model and veterinary care facility supporting biomedical research, medical device testing, immune therapies and surgical innovation studies, with animal models, veterinary care and operating rooms made available to external universities, hospitals and organisations under contract and collaboration, plus reproductive biology and infertility biomarker research.

19Investigational Therapeutics Department
CategoryResearch service
Description

Department overseeing investigational therapies from discovery through real-world evidence generation, managing industry and CRO partnerships, trial training programmes and digital enablement such as Arabic-language patient portals, including sponsor-funded investigational therapies and cost avoidance where trial participants receive industry-sponsored therapies.

20Altakhassusi (KFSH App) patient portal and mobile app
CategoryDigital product / patient portal
Description

Secure patient-facing portal and mobile app (iOS and Android) for patients to manage appointments, access medical records and Personal Health Records, view test results, find doctors and follow up after visits.

21e-Services (General and Patient e-Services)
CategoryDigital service
Description

Online hospital services covering appointment booking, referral initiation, patient information and family or visitor guidance, delivered through the web portal and the KFSH App, including self-booking of appointments and access to test results and medical records 24/7.

22iLearn Learning Management System
CategoryEducation platform
Description

KFSHRC's learning management system giving staff and students anytime access to courses, training materials and professional development resources across more than 200 specialised training programmes.

23Motamarat
CategoryEducation platform / app
Description

Custom-built application for managing continuing medical education conferences, workshops and courses with streamlined registration and certification for clinicians and external participants.

24AI-Powered ECG Analysis
CategoryAI product / clinical decision support
Description

In-house AI capability developed by KFSHRC to analyse electrocardiograms, supporting early detection of cardiac conditions and clinical decision-making for the hospital's clinical teams.

25AI Platform for CAR T-Cell Therapy Eligibility and Risk Assessment
CategoryAI product / clinical decision support
Description

AI platform that assesses patient eligibility for CAR T-cell therapy and produces risk assessments from clinical and laboratory records, part of KFSHRC's applied-AI portfolio for haematologic oncology.

26Applied AI Ecosystem in Radiology
CategoryAI platform / infrastructure
Description

Hospital-wide model for deploying artificial intelligence across radiology workflows, positioning AI as core infrastructure for image interpretation and for scaling tertiary care transformation beyond pilots.

27Integrated Robotic Surgery Platform
CategoryClinical technology platform
Description

Robotic surgery capability deployed across specialties, including the integrated robotic system used for deep brain stimulation and the single-port robotic systems used for liver transplant and living donor liver resection procedures.

Scale indicator20 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1Oracle
Strategic tierFlagship Strategic Technology Partnership To Advance Healthcare Innovation In Saudi ArabiaTypeTechnology or IntegrationAnnounced on2026-10-01
Description

Oracle and King Faisal Specialist Hospital & Research Centre announced a collaboration to advance healthcare innovation in Saudi Arabia. Announced via Oracle's own newsroom on 2026-10-01 and distributed via WebWire on 2026-10-02. The partnership builds on KFSHRC's position of artificial intelligence as core infrastructure in healthcare delivery and its integrated digital systems agenda under Deputy Group CEO Dr. Björn Zoëga.

webwire.com
2Almather Hospital
Strategic tierMajor Network Expansion In The Eastern RegionTypeStrategic or Co-development PartnerAnnounced on2026-08-31
Description

H.E. Dr. Majid Alfayyadh, Group CEO of KFSHRC, inaugurated Almather Hospital in connection with King Faisal Specialist Hospital & Research Centre, extending the KFSH&RC network and clinical model to a new hospital site.

einpresswire.com
3Axelerated Solutions
Strategic tierCore Vendor Relationship For Computing InfrastructureTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-07-16
Description

Axelerated Solutions signed a computing services contract with KFSHRC. The agreement provides computing services to King Faisal Specialist Hospital & Research Centre, supporting the hospital's technology infrastructure and integrated digital systems.

argaam.com
4HLTH Europe 2026
Strategic tierFlagship Annual Industry Forum ParticipationTypeStrategic or Co-development PartnerAnnounced on2026-06-16
Description

KFSH showcased its applied AI ecosystem in radiology and its innovation infrastructure as the foundation for sustainable healthcare transformation at HLTH Europe 2026, emphasising capability building and the strategic value of tertiary care AI datasets for precision medicine.

globenewswire.com
5World Economic Forum
Strategic tierGlobal Forum Participant / Thought-Leadership PartnershipTypeStrategic or Co-development PartnerAnnounced on2026-05-18
Description

KFSH joined the World Economic Forum Annual Health Roundtable 2026 to advance global dialogue on AI in healthcare, and spotlighted the rise of emerging AI-health leaders at the roundtable.

einpresswire.com
6Trilateral Commission
Strategic tierInternational Policy Dialogue ParticipationTypeStrategic or Co-development PartnerAnnounced on2026-05-16
Description

KFSH joined global leaders at the Trilateral Commission Tokyo Plenary Meeting to shape the future of AI and digital healthcare, showcasing Saudi healthcare innovation and calling for scaling AI beyond pilot programs.

einpresswire.com
7Milken Institute
Strategic tierSilver Sponsorship Of The Milken Institute Global Conference 2026TypeGTM or Marketing PartnerAnnounced on2026-04-27
Description

KFSH participated in the Milken Institute Global Conference 2026 in Beverly Hills, California as a Silver Sponsor, bringing an AI-as-infrastructure approach to healthcare and extending care across a national network.

globenewswire.com
8C3 Davos of Healthcare
Strategic tierFlagship Global Strategic Partner DesignationTypeStrategic or Co-development PartnerAnnounced on2026-04-20
Description

KFSH joined C3 Davos of Healthcare 2026 in Sunnyvale, California as a Global Strategic Partner, showcasing a scalable AI integration model and awarding winners of the KFSH Innovation Challenge at the Silicon Valley Summit.

globenewswire.com
9Qiddiya
Strategic tierFlagship National Development Project PartnershipTypeStrategic or Co-development PartnerAnnounced on2026-04-13
Description

Qiddiya teamed up with KFSH to set up a premium sports medical centre in Riyadh. The partnership extends KFSH&RC's specialised tertiary care model into the Kingdom's sports and entertainment ecosystem, aligned with the Qiddiya giga-project development.

zawya.com
10Global Alliance for Genomics and Health
Strategic tierCore International Research Alliance MembershipTypeStrategic or Co-development PartnerAnnounced on2026-03-09
Description

KFSH joined a prestigious global alliance for genomics and health, extending its genomic medicine programme and international standards alignment in genomic data sharing and clinical translation.

einpresswire.com
11King Abdulaziz City for Science and Technology (KAUST)
Strategic tierCore National Research CollaborationTypeStrategic or Co-development Partner
Description

KFSH&RC is one of the leading centres of the Saudi Human Genome Program supported by KAUST. KFSH researchers collaborate with KAUST, whose researchers innovate stain-free imaging technology to accelerate cancer diagnosis in work described in the 'Stain-Free Imaging Platform from KAUST Enhances Cancer Diagnostics' release.

kfshrc.edu.sa
12Alfaisal University
Strategic tierCore Academic Affiliation For Medical EducationTypeImplementation/ SI/ Consulting Partner
Description

Medical students attend an arranged clinical training medical programme in collaboration with Alfaisal University during their 4th-5th year, and KFSH&RC's training programmes are affiliated with Alfaisal University.

kfshrc.edu.sa
13Princess Nora bin Abdulrahman University
Strategic tierSecondary Academic Affiliation For Medical EducationTypeImplementation/ SI/ Consulting Partner
Description

KFSH&RC's Undergraduate Medical Education coordinates with affiliated universities, including Princess Nora bin Abdulrahman University, to accept visiting medical students for clinical training.

kfshrc.edu.sa
Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
1King Abdullah Specialized Children’s Hospital
TypeRegional player
Description

Saudi tertiary children's hospital in Riyadh operating oncology, transplant and paediatric specialty programmes under the same Ministry of Health ecosystem, making it the closest domestic comparator for complex paediatric and cancer care volumes.

2King Fahad Medical City
TypeRegional player
Description

Saudi Arabia's largest tertiary referral complex with organ transplant, oncology and cardiac programmes and an embedded research arm — directly competing for national and international referral volumes.

3King Saud University Medical City
TypeRegional player
Description

Riyadh-based academic medical centre combining tertiary hospital, teaching and research functions, structurally similar to KFSHRC's hospital-plus-research-centre model and competing for academic affiliation and clinical trial sites.

4Cleveland Clinic Abu Dhabi
TypeRegional player
Description

Multi-specialty tertiary and quaternary hospital in the Gulf serving regional and international patients with transplant, cardiac and oncology care, a direct competitor for medical-tourism and complex-case referrals.

5Sheikh Khalifa Medical City (SKMC)
TypeRegional player
Description

UAE flagship tertiary hospital and academic centre with transplant, oncology and clinical trial programmes plus an in-house medical education academy — closely comparable in scale and service mix.

6Charité – Universitätsmedizin Berlin
TypeBroad incumbent
Description

University hospital with dedicated Centres of Excellence in oncology, transplant and cardiovascular care, a benchmark for the specialised-centre structure and outcome-transparency model KFSHRC is building.

7Royal Marsden NHS Foundation Trust
TypeBroad incumbent
Description

World-specialist cancer centre with large trial and genomics programmes; its CEO sits on the KFSHRC board, making it both a benchmark peer and a governance reference.

8Johns Hopkins Medicine
TypeBroad incumbent
Description

Academic medical centre integrating hospital, research and clinical trial operations at global scale, comparable for translational research infrastructure and international referral capture.

9Siemens Healthineers
TypeOthers
Description

Supplies imaging, radiopharmacy and clinical technology to hospitals globally, an ecosystem participant positioned to partner with or compete against in-house capabilities such as KFSHRC's cyclotron manufacturing and radiology AI.

10GE HealthCare
TypeOthers
Description

Provides imaging equipment, radiopharmaceutical distribution and AI imaging software to hospital customers, overlapping with KFSHRC's radiology AI ecosystem and nuclear medicine supply chain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

King Faisal Specialist Hospital and Research

Tertiary Care Hospital Serviceskfshrc.edu.sa

State-linked Saudi hospital and research institution operating campuses in Riyadh, Jeddah, Madinah and Almather, delivering tertiary and quaternary transplant, oncology, cardiac and genomic medicine to 4M+ patients a year, funded by patient billing and health insurance reimbursement.

What King Faisal Specialist Hospital and Research does

King Faisal Specialist Hospital and Research Centre (KFSH&RC) is a state-linked, non-traded healthcare and research institution founded in 1975 and headquartered in Riyadh, Kingdom of Saudi Arabia. It operates hospital campuses in Riyadh (over 1,500 inpatient beds, the flagship and main research center), Jeddah (approximately 470 beds, with a telemedicine network linked to Riyadh) and Madinah (a 300-bed smart hospital), and added Almather Hospital as a fourth site in August 2026. Care delivery is organized into named Centres of Excellence (Cancer, Organ Transplant, Heart, Genomics Medicine, Medical, Neuroscience, Surgical, Pediatrics & Women's, Clinical Services, Perioperative & Intensive Care) covering more than 65 specialties, with 1,092 organ transplants performed in a single year and 4M+ patients treated annually across 107+ nationalities by over 13,500 professionals drawn from more than 67 nationalities, including 1,750 doctors. Governance sits with a 13-member Board chaired by Mr. Mazin Alromaih (since 2023), whose membership includes the Ministry of Health, Ministry of Finance, Public Investment Fund, Center for National Health Insurance and the Council of Economic and Development Affairs; the entity has no disclosed parent, holding company or equity investors and trades as a non-listed institutional provider rather than a for-profit corporate.

The underlying technical base combines clinical, manufacturing and research assets. Surgical capability includes fully robotic and single-port robotic platforms that produced the world's first fully robotic heart transplant, the world's first fully robotic liver transplant and a world-first single-port robotic living donor liver resection, plus integrated robotic deep brain stimulation. In-house additive manufacturing (fused deposition modeling, stereolithography, digital light processing and multi-jetting) produces surgical planning models, biocompatible cutting guides, orthotics and prosthetics. Radiopharmaceuticals are manufactured on three on-site cyclotrons, supplying more than 30 PET and SPECT agents to around 50 hospitals in Saudi Arabia under international GMP and SFDA standards, and the Secondary Standards Dosimetry Laboratory operates as an IAEA-recognized Collaborating Centre and national/regional dosimetry reference. The research arm under Chief Research and Innovation Officer Prof. Jackie Y. Ying integrates biomarker discovery, multi-omics, bioinformatics and AI, with over 200 primary patents granted or pending (42 licensed to multinational and start-up companies) and an integrated genomic medicine model highlighted by Nature Genetics. Digital access runs through the Altakhassusi patient portal/app, e-Services, referral entry, the 199019 helpline, iLearn, Motamarat and the iSupplier portal; no public or partner-facing developer API is exposed.

Economically the institution runs a transaction-based clinical model: revenue comes from tertiary and quaternary patient care (beds, intensive care, surgery, transplantation, oncology, specialist consultations) collected through patient billing and third-party health insurance reimbursement, with billing and insurance data shared with insurers for payment and coverage, and a separate patient-accounts function operated through the Admission Office. Non-clinical lines are smaller but meaningful: radiopharmaceutical product supply to external hospitals (usage-based), clinical trial management and investigational therapeutics including sponsor-funded therapies (four high-impact partnership agreements plus roughly one new agreement annually, alongside CRO and contract research services), 3D printing services, comparative medicine contract research under AAALAC accreditation, and education and training programs spanning 66 residency and 27 fellowship tracks. Patient charges, insurance tariffs and research-service fees are not publicly disclosed, so pricing mechanics and payer mix are not observable from the source data.

King Faisal Specialist Hospital and Research firmographics

Firmographics
Name
King Faisal Specialist Hospital and Research
Legal name
King Faisal Specialist Hospital and Research Center
Website
https://kfshrc.edu.sa
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
10,001+ employees
Short description
State-linked Saudi hospital and research institution operating campuses in Riyadh, Jeddah, Madinah and Almather, delivering tertiary and quaternary transplant, oncology, cardiac and genomic medicine to 4M+ patients a year, funded by patient billing and health insurance reimbursement.
Ownership category
akta.pro rank

King Faisal Specialist Hospital and Research industry classification

Industry
Product category
Tertiary Care Hospital Services
NAICS
Hospitals (622), General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)
SIC
Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAHAA
Cardiac & Cardiothoracic Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAAAM
Hospital-Integrated Cancer Centers (Acute Oncology Programs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
SECONDARYHLAFAKAB
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)

Keywords

  • Tertiary and quaternary healthcare
  • Specialist hospital services
  • Organ transplantation programs
  • Oncology treatment services
  • Clinical research services

Where King Faisal Specialist Hospital and Research is headquartered

Location

Headquarters

HQ city
Riyadh
HQ country
Saudi Arabia
HQ region
Middle East

Offices3 records

Markets served

King Faisal Specialist Hospital and Research business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Clinical services (patient care and treatment): Revenue is generated from the delivery of tertiary and quaternary clinical care across three hospital campuses (Riyadh, Jeddah, Madinah), including inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations. Billing data (health data used for billing purposes) and insurance data (bank account details, health insurance details, credit/debit cards) are collected and shared with insurers for payment and coverage, indicating third-party payer reimbursement as a core collection mechanism.
  2. Radiopharmaceutical manufacturing (supply to hospitals): The Cyclotron and Radiopharmaceuticals unit produces on-demand ready-to-use doses of more than 30 radiopharmaceuticals supplied to around 50 hospitals throughout Saudi Arabia, under international GMP and SFDA standards — a product supply revenue line to external institutional customers.
  3. Clinical trials and investigational therapeutics: Clinical trial management services, including sponsor-funded investigational therapies and cost avoidance where trial participants receive industry-sponsored therapies that the institution would otherwise fund; includes four high-impact partnership agreements with one new agreement annually, plus CRO/contract research services.
  4. 3D printing and custom medical device services: Award-winning in-house 3D printing service offered to clinical and research departments and external organisations, covering surgical planning models, biocompatible cutting guides, orthotics and prosthetics, and research prototypes.
  5. Comparative medicine contract research organization services: Animal models, veterinary care and operating rooms made available to external organisations under contract and collaboration, including medical device testing, immune therapies and surgical innovation studies for local and international universities and hospitals.
  6. Education, training and professional development programs: Academic & Training Affairs runs undergraduate, postgraduate (66 residency and 27 fellowship programs), non-medical training, simulation centre and continuing medical education programs, plus scholarships, some with international accreditation, open to employees, interns/students and external organisations.

Go-to-market motion4 records

Distribution channels6 records

King Faisal Specialist Hospital and Research product offering

Product offering

Core offering

King Faisal Specialist Hospital & Research Centre provides tertiary and quaternary hospital care through three campuses in Riyadh, Jeddah and Madinah, covering inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations across more than 65 specialties. Its care is organised into named Centres of Excellence (including Cancer, Organ Transplant, Heart, Genomics Medicine, Neurosciences, Surgical and Perioperative & Intensive Care) and is extended by an in-house Research Centre that sells contract research services such as clinical trials management, 3D printing, radiopharmaceutical manufacturing and dosimetry calibration.

Product overview

KFSH&RC operates not a single software product but a multi-campus healthcare and research platform: three hospital campuses (Riyadh, Jeddah, Madinah) plus the new Almather Hospital, organized into named Centres of Excellence (Cancer, Organ Transplant, Heart, Genomics Medicine, Medical, Neuroscience, Surgical, Pediatrics & Women's, Clinical Services and Perioperative & Intensive Care), supported by a set of standalone Research Services (Biomedical Physics, Clinical Trials, Comparative Medicine, Cyclotron and Radiopharmaceuticals, Investigational Therapeutics, Research Regulation and Compliance and 3D Printing) and a digital layer of patient-facing and staff-facing platforms (the Altakhassusi/KFSH App patient portal, e-Services, iLearn learning platform, Motamarat CME app, Health Sciences Digital Library and the iSupplier portal). On top of these foundations KFSH&RC layers a growing applied-AI product set (AI-powered ECG analysis, a CAR T-cell eligibility and risk assessment platform, and an applied AI ecosystem for radiology), alongside an in-house 3D printing service for precision surgery and robotic surgery platforms used in transplant and neurosurgical programs.

Differentiator

Problem solved

Functional benefit

Brands

  • Altakhassusi (KFSH App): Patient mobile application and personal health records portal used to manage appointments, access medical records, view test results and find doctors; also published as the Altakhassusi medical record service.
  • Motamarat
  • iLearn
  • Secondary Standards Dosimetry Laboratory (SSDL)

Products and services

  • KFSH&RC Riyadh Hospital Flagship 1,500-bed hospital and main research centre of KFSH&RC, delivering advanced medical and surgical care for patients across Saudi Arabia and internationally, leading organ transplantation, cancer treatment and genomic medicine programmes; JCI-accredited and home of the world's first fully robotic heart transplant.
  • KFSH&RC Jeddah Hospital Approximately 470-bed specialist care, training and research campus on the Red Sea coast with general and specialised wards, advanced cardiac care, paediatric surgery and oncology units, and a telemedicine network linked to Riyadh for complex consultations.
  • KFSH&RC Madinah Hospital Newest 300-bed hospital in the network in the Holy City, featuring smart hospital systems, smart rooms, an infusion centre and operating theatres, with a focus on cancer, ophthalmology, critical care and women's health.
  • Organ Transplant Centre of Excellence Twelve-specialty centre leading the Middle East in organ transplantation, performing 1,092 organ transplants in a single year, including the world's first fully robotic liver transplant, and the world's first single-port robotic living donor liver resection.
  • Heart Centre of Excellence Five-specialty centre operating the only active heart transplant programme in the Kingdom of Saudi Arabia and the Gulf region and the largest in Asia Pacific, ranking among the top 10% of transplant centres worldwide; home of the world's first fully robotic heart transplant.
  • Cancer Centre of Excellence Described as the Gulf's largest premier cancer facility with seven specialties, treating nearly a quarter of all cancer cases in Saudi Arabia annually, backed by the King Abdullah Center for Oncology and Liver Diseases (KACOLD) with 300 smart-room beds, 96 infusion centre beds and 8 operating theatres.
  • Genomics Medicine Centre of Excellence Four-specialty centre applying genomic testing to tailor treatments to individual genetic profiles, linked to KFSHRC's integrated genomic medicine model that was highlighted by Nature Genetics as it scaled genomic medicine from research into clinical decision-making.
  • Medical Centre of Excellence Eight expert teams under one roof spanning immunology, endocrinology, gastroenterology, infectious diseases, internal medicine, nephrology, pulmonary medicine and rheumatology.
  • Neuroscience Centre of Excellence Eight-specialty multidisciplinary centre delivering treatments for brain tumours, stroke, epilepsy and movement disorders, including robotic deep brain stimulation and stereoelectroencephalography procedures.
  • Surgical Centre of Excellence Six-specialty surgical centre covering minimally invasive and complex operations, supported by the hospital's integrated robotic surgery platform and by in-house 3D printing for surgical planning models and biocompatible cutting guides.
  • Pediatrics & Women's Centre of Excellence Three-specialty centre offering specialised paediatric treatments, including the King Fahad National Centre for Children's Cancer and the largest regional paediatric stem cell transplant programme, and comprehensive women's health services for families.
  • Clinical Services Centre of Excellence Clinical services hub within KFSH&RC's Centres of Excellence, grouping specialised clinical service lines delivered across the network's hospital campuses.
  • Perioperative & Intensive Care Centre of Excellence Perioperative services and intensive care unit capability supporting complex surgery, including the Riyadh campus's advanced intensive care units.
  • 3D Printing Service On-site additive manufacturing service using fused deposition modeling, stereolithography, digital light processing and multi-jetting, offered to clinical and research departments and external organisations for surgical planning models, biocompatible cutting guides, custom orthotics and prosthetics, and research prototypes and bioprinting.
  • Clinical Trials Unit Central hub coordinating end-to-end clinical trial management from activation to completion for sponsors, CROs and investigators, advising on feasibility and trial operations; almost half of all active clinical trials in Saudi Arabia are conducted at KFSHRC.
  • Cyclotron and Radiopharmaceuticals On-demand production of more than 30 different PET and SPECT radiopharmaceuticals using three on-site cyclotrons under international GMP and SFDA standards, supplying ready-to-use patient doses to around 50 hospitals throughout Saudi Arabia, with quality control covering radionuclide identification, radiochemical purity, pH, sterility and residual solvents.
  • Biomedical Physics Department (incl. Secondary Standards Dosimetry Laboratory) Medical physics, radiation protection, quality assurance, calibration and dosimetry services; its Secondary Standards Dosimetry Laboratory is an IAEA-recognised Collaborating Centre and a national and regional reference centre for radiation dosimetry providing traceable calibration to international primary standards.
  • Comparative Medicine AAALAC-accredited animal model and veterinary care facility supporting biomedical research, medical device testing, immune therapies and surgical innovation studies, with animal models, veterinary care and operating rooms made available to external universities, hospitals and organisations under contract and collaboration, plus reproductive biology and infertility biomarker research.
  • Investigational Therapeutics Department Department overseeing investigational therapies from discovery through real-world evidence generation, managing industry and CRO partnerships, trial training programmes and digital enablement such as Arabic-language patient portals, including sponsor-funded investigational therapies and cost avoidance where trial participants receive industry-sponsored therapies.
  • Altakhassusi (KFSH App) patient portal and mobile app Secure patient-facing portal and mobile app (iOS and Android) for patients to manage appointments, access medical records and Personal Health Records, view test results, find doctors and follow up after visits.
  • e-Services (General and Patient e-Services) Online hospital services covering appointment booking, referral initiation, patient information and family or visitor guidance, delivered through the web portal and the KFSH App, including self-booking of appointments and access to test results and medical records 24/7.
  • iLearn Learning Management System KFSHRC's learning management system giving staff and students anytime access to courses, training materials and professional development resources across more than 200 specialised training programmes.
  • Motamarat Custom-built application for managing continuing medical education conferences, workshops and courses with streamlined registration and certification for clinicians and external participants.
  • AI-Powered ECG Analysis In-house AI capability developed by KFSHRC to analyse electrocardiograms, supporting early detection of cardiac conditions and clinical decision-making for the hospital's clinical teams.
  • AI Platform for CAR T-Cell Therapy Eligibility and Risk Assessment AI platform that assesses patient eligibility for CAR T-cell therapy and produces risk assessments from clinical and laboratory records, part of KFSHRC's applied-AI portfolio for haematologic oncology.
  • Applied AI Ecosystem in Radiology Hospital-wide model for deploying artificial intelligence across radiology workflows, positioning AI as core infrastructure for image interpretation and for scaling tertiary care transformation beyond pilots.
  • Integrated Robotic Surgery Platform Robotic surgery capability deployed across specialties, including the integrated robotic system used for deep brain stimulation and the single-port robotic systems used for liver transplant and living donor liver resection procedures.

Quantifiable outcome

  • Reduced cost of CAR-T therapy by 80 percent
  • +9 more outcomes

Companies that use King Faisal Specialist Hospital and Research

Customer profile

Named customers3 records

Ideal customer profiles5 records

King Faisal Specialist Hospital and Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability9 records

Feature13 records

King Faisal Specialist Hospital and Research partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered flagship strategic technology partnership to advance healthcare innovation in saudi arabia, major network expansion in the eastern region, core vendor relationship for computing infrastructure, flagship annual industry forum participation, global forum participant / thought-leadership partnership, international policy dialogue participation, silver sponsorship of the milken institute global conference 2026, flagship global strategic partner designation, flagship national development project partnership, core international research alliance membership, core national research collaboration, core academic affiliation for medical education and secondary academic affiliation for medical education.

  • Oracleflagship strategic technology partnership to advance healthcare innovation in saudi arabiaTechnology or Integration · 1 October 2026Oracle and King Faisal Specialist Hospital & Research Centre announced a collaboration to advance healthcare innovation in Saudi Arabia. Announced via Oracle's own newsroom on 2026-10-01 and distributed via WebWire on 2026-10-02. The partnership builds on KFSHRC's position of artificial intelligence as core infrastructure in healthcare delivery and its integrated digital systems agenda under Deputy Group CEO Dr. Björn Zoëga.
  • Almather Hospitalmajor network expansion in the eastern regionStrategic or Co-development Partner · 31 August 2026H.E. Dr. Majid Alfayyadh, Group CEO of KFSHRC, inaugurated Almather Hospital in connection with King Faisal Specialist Hospital & Research Centre, extending the KFSH&RC network and clinical model to a new hospital site.
  • Axelerated Solutionscore vendor relationship for computing infrastructureImplementation/ SI/ Consulting Partner · 16 July 2026Axelerated Solutions signed a computing services contract with KFSHRC. The agreement provides computing services to King Faisal Specialist Hospital & Research Centre, supporting the hospital's technology infrastructure and integrated digital systems.
  • HLTH Europe 2026flagship annual industry forum participationStrategic or Co-development Partner · 16 June 2026KFSH showcased its applied AI ecosystem in radiology and its innovation infrastructure as the foundation for sustainable healthcare transformation at HLTH Europe 2026, emphasising capability building and the strategic value of tertiary care AI datasets for precision medicine.
  • World Economic Forumglobal forum participant / thought-leadership partnershipStrategic or Co-development Partner · 18 May 2026KFSH joined the World Economic Forum Annual Health Roundtable 2026 to advance global dialogue on AI in healthcare, and spotlighted the rise of emerging AI-health leaders at the roundtable.
  • Trilateral Commissioninternational policy dialogue participationStrategic or Co-development Partner · 16 May 2026KFSH joined global leaders at the Trilateral Commission Tokyo Plenary Meeting to shape the future of AI and digital healthcare, showcasing Saudi healthcare innovation and calling for scaling AI beyond pilot programs.
  • Milken Institutesilver sponsorship of the milken institute global conference 2026GTM or Marketing Partner · 27 April 2026KFSH participated in the Milken Institute Global Conference 2026 in Beverly Hills, California as a Silver Sponsor, bringing an AI-as-infrastructure approach to healthcare and extending care across a national network.
  • C3 Davos of Healthcareflagship global strategic partner designationStrategic or Co-development Partner · 20 April 2026KFSH joined C3 Davos of Healthcare 2026 in Sunnyvale, California as a Global Strategic Partner, showcasing a scalable AI integration model and awarding winners of the KFSH Innovation Challenge at the Silicon Valley Summit.
  • Qiddiyaflagship national development project partnershipStrategic or Co-development Partner · 13 April 2026Qiddiya teamed up with KFSH to set up a premium sports medical centre in Riyadh. The partnership extends KFSH&RC's specialised tertiary care model into the Kingdom's sports and entertainment ecosystem, aligned with the Qiddiya giga-project development.
  • Global Alliance for Genomics and Healthcore international research alliance membershipStrategic or Co-development Partner · 9 March 2026KFSH joined a prestigious global alliance for genomics and health, extending its genomic medicine programme and international standards alignment in genomic data sharing and clinical translation.
  • King Abdulaziz City for Science and Technology (KAUST)core national research collaborationStrategic or Co-development PartnerKFSH&RC is one of the leading centres of the Saudi Human Genome Program supported by KAUST. KFSH researchers collaborate with KAUST, whose researchers innovate stain-free imaging technology to accelerate cancer diagnosis in work described in the 'Stain-Free Imaging Platform from KAUST Enhances Cancer Diagnostics' release.
  • Alfaisal Universitycore academic affiliation for medical educationImplementation/ SI/ Consulting PartnerMedical students attend an arranged clinical training medical programme in collaboration with Alfaisal University during their 4th-5th year, and KFSH&RC's training programmes are affiliated with Alfaisal University.
  • Princess Nora bin Abdulrahman Universitysecondary academic affiliation for medical educationImplementation/ SI/ Consulting PartnerKFSH&RC's Undergraduate Medical Education coordinates with affiliated universities, including Princess Nora bin Abdulrahman University, to accept visiting medical students for clinical training.

Scale indicators20 records

Recent moves10 records

Expansion highlights8 records

King Faisal Specialist Hospital and Research competitors and assessment

Company assessment

Regional players

  • King Abdullah Specialized Children’s Hospital: Saudi tertiary children's hospital in Riyadh operating oncology, transplant and paediatric specialty programmes under the same Ministry of Health ecosystem, making it the closest domestic comparator for complex paediatric and cancer care volumes.
  • King Fahad Medical City: Saudi Arabia's largest tertiary referral complex with organ transplant, oncology and cardiac programmes and an embedded research arm — directly competing for national and international referral volumes.
  • King Saud University Medical City: Riyadh-based academic medical centre combining tertiary hospital, teaching and research functions, structurally similar to KFSHRC's hospital-plus-research-centre model and competing for academic affiliation and clinical trial sites.
  • Cleveland Clinic Abu Dhabi: Multi-specialty tertiary and quaternary hospital in the Gulf serving regional and international patients with transplant, cardiac and oncology care, a direct competitor for medical-tourism and complex-case referrals.
  • Sheikh Khalifa Medical City (SKMC): UAE flagship tertiary hospital and academic centre with transplant, oncology and clinical trial programmes plus an in-house medical education academy — closely comparable in scale and service mix.

Broad incumbents

  • Charité – Universitätsmedizin Berlin: University hospital with dedicated Centres of Excellence in oncology, transplant and cardiovascular care, a benchmark for the specialised-centre structure and outcome-transparency model KFSHRC is building.
  • Royal Marsden NHS Foundation Trust: World-specialist cancer centre with large trial and genomics programmes; its CEO sits on the KFSHRC board, making it both a benchmark peer and a governance reference.
  • Johns Hopkins Medicine: Academic medical centre integrating hospital, research and clinical trial operations at global scale, comparable for translational research infrastructure and international referral capture.

Others

  • Siemens Healthineers: Supplies imaging, radiopharmacy and clinical technology to hospitals globally, an ecosystem participant positioned to partner with or compete against in-house capabilities such as KFSHRC's cyclotron manufacturing and radiology AI.
  • GE HealthCare: Provides imaging equipment, radiopharmaceutical distribution and AI imaging software to hospital customers, overlapping with KFSHRC's radiology AI ecosystem and nuclear medicine supply chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

King Faisal Specialist Hospital and Research social profiles

Digital presence

King Faisal Specialist Hospital and Research compliance and trust

Trust signal

Compliance11 records

King Faisal Specialist Hospital and Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

King Faisal Specialist Hospital and Research leadership team

Management profile

Number of profiles

Profiles14 records

King Faisal Specialist Hospital and Research subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

King Faisal Specialist Hospital and Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

King Faisal Specialist Hospital and Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about King Faisal Specialist Hospital and Research

What does King Faisal Specialist Hospital and Research do?

King Faisal Specialist Hospital & Research Centre provides tertiary and quaternary hospital care through three campuses in Riyadh, Jeddah and Madinah, covering inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations across more than 65 specialties. Its care is organised into named Centres of Excellence (including Cancer, Organ Transplant, Heart, Genomics Medicine, Neurosciences, Surgical and Perioperative & Intensive Care) and is extended by an in-house Research Centre that sells contract research services such as clinical trials management, 3D printing, radiopharmaceutical manufacturing and dosimetry calibration.

Is King Faisal Specialist Hospital and Research a public or private company?

King Faisal Specialist Hospital and Research is a private company. It is classified as state government owned and is currently operating.

When was King Faisal Specialist Hospital and Research founded?

King Faisal Specialist Hospital and Research was founded in 1975. It employs 10,001+ people.

Where is King Faisal Specialist Hospital and Research based?

King Faisal Specialist Hospital and Research is headquartered in Riyadh, Saudi Arabia, in the Middle East region.

How does King Faisal Specialist Hospital and Research make money?

Six revenue lines are on record. Clinical services (patient care and treatment) is the primary driver. The others are radiopharmaceutical manufacturing (supply to hospitals), clinical trials and investigational therapeutics, 3D printing and custom medical device services, comparative medicine contract research organization services and education, training and professional development programs.

Who are King Faisal Specialist Hospital and Research's main competitors?

Regional players on record are King Abdullah Specialized Children’s Hospital, King Fahad Medical City, King Saud University Medical City, Cleveland Clinic Abu Dhabi and Sheikh Khalifa Medical City (SKMC). Broad incumbents are Charité – Universitätsmedizin Berlin, Royal Marsden NHS Foundation Trust and Johns Hopkins Medicine. Others are Siemens Healthineers and GE HealthCare.

Does King Faisal Specialist Hospital and Research have an API?

No public API is recorded for King Faisal Specialist Hospital and Research.

What industry is King Faisal Specialist Hospital and Research in?

King Faisal Specialist Hospital and Research's product category is Tertiary Care Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFAHAA, Cardiac & Cardiothoracic Specialty Hospitals. Its NAICS code is 622 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinanzNachrichten.deKing Faisal Specialist Hospital & Research Centre: KFSH Riyadh gewinnt Davos Healthcare Global Elite Five-Star Medallion und zählt zu den besten 5 % der bewerteten KrankenhäuserKing Faisal Specialist Hospital & Research Centre in Riyadh received the Davos Healthcare Global Elite Five-Star Medallion, placing it among the top 5% of evaluated hospitals. The award is based on AI analysis of public data across four areas, and the hospital led 1,685 robotic surgeries in 2025. It also ranked first in the Middle East and Africa among 250 leading academic medical centers.EIN PresswireWhy Nurses Stay at KFSH: Wellbeing at the Heart of RetentionKing Faisal Specialist Hospital and Research Centre reduced nursing turnover from 6.7% in 2024 to 3.27% in 2025, placing wellbeing and recognition at the center of its strategy. The hospital's Code Lavender program won the 2026 Healthy Work Environment Award from Sigma Theta Tau International. Lower turnover ensures continuity of care for patients in complex specialties.EIN PresswireBedside Prevention Sharply Reduces Ventilator-Associated Pneumonia at KFSHKing Faisal Specialist Hospital and Research Centre reduced ventilator-associated pneumonia by 74% in 2025 compared with 2024, alongside a 29% drop in central line-associated bloodstream infections and a 30% drop in surgical site infections. The hospital attributes the results to evidence-based prevention protocols and consistent adherence to best practice.MDPIClinical, Endocrine, and Reproductive Profiles of Patients with Primary Ovarian Insufficiency at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia: A Retrospective AnalysisA retrospective study of 64 patients with primary ovarian insufficiency at a Saudi hospital found onset before age 20 in 64.1%, with infertility (50%) and menstrual disturbances (42.2%) as common symptoms. Autoimmune diseases were present in 60.9% of patients, and vitamin D deficiency in 71.4%. The data do not support a predominant underlying etiology.ArabnewsSaudi hospital jumps 107 places in global smart hospitals rankingsKing Faisal Specialist Hospital & Research Centre climbed 107 places to 123rd in Newsweek's 2027 smart hospital rankings. It earned two top honors, including the highest digital maturity rating and AI innovation distinction. The hospital uses AI for predictive analytics and robotic transplants.EIN PresswireKFSH Uses Digital Twins to Let Surgeons Rehearse Patient-Specific Procedures Before OperatingKing Faisal Specialist Hospital and Research Centre is using digital-twin technology to let surgical teams rehearse patient-specific procedures before operating. The hospital reports that planning with digital twins supports shorter operating times and faster recovery. KFSH is ranked first in the Middle East and Africa and 12th globally among top 250 academic medical centers for 2026.Financial PostKFSH Strengthens Patient-Centered Care With ICHOM AccreditationKing Faisal Specialist Hospital and Research Centre earned Level 1 ICHOM accreditation for its cataract surgery program, using standardized measures including the Catquest-9SF questionnaire. The hospital plans to expand patient-reported outcome measurement to additional clinical specialties.EIN PresswireKFSH Advances Patient-Centered Care Through ICHOM AccreditationKing Faisal Specialist Hospital and Research Centre earned Level 1 ICHOM accreditation for its cataract surgery program, implementing standardized measures including the Catquest-9SF questionnaire. The hospital shares surgeon results openly and plans to expand patient-reported outcome measurement to additional specialties.GlobeNewswireKFSH Strengthens Patient-Centered Care With ICHOM AccreditationKing Faisal Specialist Hospital and Research Centre earned Level 1 ICHOM accreditation for its cataract surgery program, implementing standardized measures including the Catquest-9SF questionnaire. The hospital plans to expand patient-reported outcome measurement to additional clinical specialties.FinanzNachrichten.deKing Faisal Specialist Hospital & Research Centre: KFSH erweitert den Zugang zur Notfallversorgung durch virtuelle Versorgung und die Koordination durch FachärzteKing Faisal Specialist Hospital and Research Centre expanded emergency access through virtual triage and specialist coordination, enabling early assessment and referral. The model supports complex cases and preserves resources for critical cases, with the hospital ranked first in the Middle East and Africa for 2026.